Literature DB >> 12488221

Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?

Núria Gironès1, Manuel Fresno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12488221     DOI： 10.1016/s1471-4922(02)00006-5

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


× No keyword cloud information.
  22 in total

1.  On the definition of a criterion of immunogenicity.

Authors:  Thomas Pradeu; Edgardo D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

2.  Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.

Authors:  Simone Garcia; Carolina O Ramos; Juliana F V Senra; Fabio Vilas-Boas; Maurício M Rodrigues; Antonio C Campos-de-Carvalho; Ricardo Ribeiro-Dos-Santos; Milena B P Soares
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 3.  Chagas disease.

Authors:  A R L Teixeira; N Nitz; M C Guimaro; C Gomes; C A Santos-Buch
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

4.  Trypanosoma cruzi antigen immunization induces a higher B cell survival in BALB/c mice, a susceptible strain, compared to C57BL/6 B lymphocytes, a resistant strain to cardiac autoimmunity.

Authors:  Andrea Pellegrini; Eugenio Antonio Carrera-Silva; Alfredo Arocena; Roxana Carolina Cano; Maria Pilar Aoki; Susana Gea
Journal:  Med Microbiol Immunol       Date:  2011-03-24       Impact factor: 3.402

5.  Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.

Authors:  Eric Dumonteil; Javier Escobedo-Ortegon; Norma Reyes-Rodriguez; Arletty Arjona-Torres; Maria Jesus Ramirez-Sierra
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.

Authors:  Ivo Santana Caldas; André Talvani; Sérgio Caldas; Cláudia Martins Carneiro; Marta de Lana; Paulo Marcos da Matta Guedes; Maria Terezinha Bahia
Journal:  Parasitol Res       Date:  2008-05-04       Impact factor: 2.289

7.  Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation.

Authors:  A R Pérez; G H Fontanella; A L Nocito; S Revelli; O A Bottasso
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

8.  Modulation of autoimmunity by treatment of an infectious disease.

Authors:  Kenneth V Hyland; Juan S Leon; Melvin D Daniels; Nick Giafis; LaKitta M Woods; Thomas J Bahk; Kegiang Wang; David M Engman
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

9.  Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.

Authors:  V Labovsky; C R Smulski; K Gómez; G Levy; M J Levin
Journal:  Clin Exp Immunol       Date:  2007-04-05       Impact factor: 4.330

10.  Decreased level of antibodies and cardiac involvement in patients with chronic Chagas heart disease vaccinated with BCG.

Authors:  Miguel Hernán Vicco; Iván Alejandro Bontempi; Luz Rodeles; Agustina Yodice; Iván Sergio Marcipar; Oscar Bottasso
Journal:  Med Microbiol Immunol       Date:  2013-12-29       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.